Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Diamorphine, also known as diacetylmorphine or heroin, is a semisynthetic opioid analgesic derived from morphine. It is primarily used in some countries for the management of severe pain, such as that associated with cancer, myocardial infarction, palliative care, pulmonary edema, and postoperative pain[2][4][6]. Diamorphine acts as a prodrug; it rapidly crosses the blood-brain barrier due to its high lipid solubility and is then metabolized into 6-monoacetylmorphine and morphine[4][5][6]. These metabolites act as potent agonists at μ-opioid (mu), κ-opioid (kappa), and δ-opioid (delta) receptors in the central nervous system[5][6], leading to analgesia by inhibiting neural activity and reducing pain transmission. The drug produces effects such as euphoria, sedation, respiratory depression, nausea, constipation, tolerance development, physical dependence and withdrawal symptoms upon cessation[5]. Diamorphine is more potent than morphine but has a very short plasma half-life of about 2–3 minutes due to rapid metabolism[5][7]. While illegal for use or sale in many countries including the United States under the name heroin[1][4], it remains an approved prescription medication for severe pain management in some regions like the United Kingdom.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on diamorphine.